top of page

Technology:
SymClot

During normal hemostasis, platelets play several key roles in the wound healing process. Upon sensing an injury, platelets become activated, changing shape to a “sticky” stellate conformation and aggregating at bleeding sites. These “sticky” activated platelets bind to each other and to the coagulation protein fibrin, which is created via polymerization of the blood protein fibrinogen and is found exclusively at bleeding sites. The resultant platelet-fibrin mesh stems blood loss. Platelets additionally exert contractile forces on the bound fibrin, pulling the fibers closer together and causing overall retraction of the clot over time. This retraction allows blood to flow to reperfuse the healing tissues and enables subsequent stages of wound healing.

Inspired by native clotting biology

Platelets - the clotting cells in blood - play many important roles in hemostasis and healing. SymClot takes inspiration from two key behaviors of platelets that occur in response to injury: homing to sites of injury and mechanically deforming clot networks to stem blood loss. By mimicking these features, SymClot can provide physiological support for clotting and healing.

Selsym_1341523969.jpg

Rapid, safe bleeding control

SymClot has been engineered to address safety and utility gaps in current care. To that end, SymClot's synthetic design renders it safe for rapid systemic injection without causing off-target clotting or adverse immune reactions.

Providing solutions across the continuum of care

SymClot has been designed for maximum utility in a wide range of uncontrolled bleeding scenarios, including:

Learn more →

Select Publications →

 

SymClot in the news​ →

bottom of page